JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.16% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
StepStone Group
STEP
$3.97B
| $104M | 0.01% |
4,297,392
+215,867
| +5% | +$5.9M |
|
777
Elanco Animal Health
ELAN
$11B
| $104M | 0.01% |
11,073,913
+7,516,372
| +211% | +$88.7M |
|
778
Globus Medical
GMED
$11.2B
| $104M | 0.01% |
1,837,425
+498,592
| +37% | +$32M |
|
|
779
CALL
Eli Lilly
LLY
$1.08T
| $104M | 0.01% |
302,300
+245,000
| +428% | +$82.6M |
|
780
EQT Corp
EQT
$33.7B
| $104M | 0.01% |
3,250,325
+35,733
| +1% | +$1.15M |
|
781
Pool Corp
POOL
$7.18B
| $104M | 0.01% |
302,815
+187,447
| +162% | +$66.5M |
|
782
PUT
ConocoPhillips
COP
$151B
| $104M | 0.01% |
1,044,500
+375,826
| +56% | +$41.1M |
|
783
Brady Corp
BRC
$4.44B
| $103M | 0.01% |
1,915,665
-94,981
| -5% | -$4.97M |
|
784
Sanofi
SNY
$104B
| $103M | 0.01% |
1,884,745
-1,591,811
| -46% | -$77.4M |
|
785
Ambev
ABEV
$43.9B
| $102M | 0.01% |
36,312,283
+754,570
| +2% | +$1.97M |
|
786
CALL
Madrigal Pharmaceuticals
MDGL
$12.4B
| $102M | 0.01% |
421,300
+411,300
| +4,113% | +$112M |
|
787
AGCO
AGCO
$7.03B
| $102M | 0.01% |
754,588
+38,185
| +5% | +$5.16M |
|
788
Plains All American Pipeline
PAA
$16.2B
| $102M | 0.01% |
8,147,138
+2,892,097
| +55% | +$36.1M |
|
789
PUT
Bank of America
BAC
$450B
| $100M | 0.01% |
3,505,100
-747,900
| -18% | -$24.7M |
|
790
iShares US Aerospace & Defense ETF
ITA
$14.9B
| $99.7M | 0.01% |
866,094
-165,584
| -16% | -$18.8M |
|
|
ITCI
791
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $99.1M | 0.01% |
1,830,884
+332,970
| +22% | +$16.1M |
|
|
EXE
792
Expand Energy Corp
EXE
$22.4B
| $98.9M | 0.01% |
1,300,566
+71,598
| +6% | +$5.89M |
|
793
Carrier Global
CARR
$51.9B
| $98.4M | 0.01% |
2,151,210
-998,779
| -32% | -$44.7M |
|
|
794
CALL
ConocoPhillips
COP
$151B
| $98.4M | 0.01% |
992,000
-220,400
| -18% | -$24.1M |
|
|
HDV
795
iShares Core High Dividend ETF
HDV
$14.9B
| $98.3M | 0.01% |
4,836,970
+205,875
| +4% | +$4.23M |
|
796
Corteva
CTVA
$50.2B
| $98.2M | 0.01% |
1,628,895
+197,226
| +14% | +$12M |
|
|
EDR
797
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $98.1M | 0.01% |
4,101,521
+527,916
| +15% | +$11.8M |
|
798
American Water Works
AWK
$27B
| $97.9M | 0.01% |
668,426
+244,260
| +58% | +$36.2M |
|
|
799
CALL
Alphabet (Google) Class A
GOOGL
$4.19T
| $97.7M | 0.01% |
941,900
+213,200
| +29% | +$20.5M |
|
800
Shell
SHEL
$248B
| $96.9M | 0.01% |
1,684,473
-378,480
| -18% | -$22.3M |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,315 increased, 2,057 reduced and 651 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 651 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.